Matrixx Braces For More Zicam Smell-Loss Suits

By Ryan Davis

Law360, New York (June 18, 2009, 12:00 AM ET) -- A U.S. Food and Drug Administration warning that Zicam nasal and cold products made by Matrixx Initiatives Inc. could cause users to lose their sense of smell will “undoubtedly” lead to more lawsuits against Matrixx, in addition to the hundreds that have already been filed, according to a company official.

William Hemelt, Matrixx's acting president, chief financial officer and chief operating officer, said in a conference call with reporters and investors on Thursday that withdrawing Zicam Cold Remedy Nasal Gel and Zicam Cold Remedy Nasal Swabs...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles